Defeat Duchenne Canada is committed to bringing the latest in Duchenne muscular dystrophy research and drug development to you – our Canadian Duchenne community. Complete the Registration Form below to receive the link.

Join us Tuesday, October 27 at 7:00 p.m. ET for a webinar sponsored by Kye Pharmaceuticals. During the webinar Dr. Sbrocchi, Pediatric Endocrinologist, and Dr. Selby, Pediatric Neuromuscular Specialist will present long-term data on AGAMREE (vamorolone). The presentation will include a review of long-term data comparing AGAMREE to classic steroids. Bring your questions and connect with our community.

Complete the Registration Form below to receive the link.